Patent Assignment
Reel/Frame 049255/0765
Assignment of Assignor's Interest
Recorded: 2019-05-22
Pages: 9
Assignors
BUCKLEY, DENNIS
Executed: 2019-01-05
BRADNER, JAMES
Executed: 2019-01-28
REMILLARD, DAVID IAN
Executed: 2019-05-10
Assignee
DANA-FARBER CANCER INSTITUTE, INC.
450 BROOKLINE AVENUE, BOSTON, MASSACHUSETTS, 02215
Covered Property
(1)
Degradation of Bromodomain-Containing Protein 9 (BRD9) by Conjugation of BRD9 Inhibitors with E3 Ligase Ligand and Methods of Use
Patent:
11,285,218 →
Application:
16/312,586 →
Publication:
US 2019/0247509
PCT:
PCT/US2017/039004 ↗